Apostrophe is an online dermatology company that provides personalized prescription skincare treatments. They connect patients with board-certified dermatologists to address concerns like acne, rosacea, fine lines, and hyperpigmentation. Users complete an online consultation, and if appropriate, a dermatologist prescribes custom medication that is then shipped directly to the patient. Apostrophe was acquired by Hims & Hers Health, Inc. in January 2021 to expand Hims & Hers' personalized dermatology offerings.
Serves as the primary hub for Apostrophe's brand operations, technology platform management, marketing initiatives, and coordination of its network of dermatologists.
While specific details of the office space are not widely publicized, facilities in this region typically feature modern, collaborative workspaces designed to foster innovation.
As part of Hims & Hers, and rooted in the tech-forward Bay Area, the culture likely emphasizes innovation, patient-centric solutions, efficiency, and a fast-paced environment typical of health-tech companies.
Being located in the Bay Area provides access to a rich talent pool in technology, healthcare, and marketing, and keeps the brand connected to the forefront of telehealth advancements.
Apostrophe's services are primarily focused on the United States market. As a brand under Hims & Hers Health, Inc., its geographic reach is aligned with Hims & Hers' operational footprint, which is predominantly US-based for its prescription services. There is no significant advertised global presence for Apostrophe's specific teledermatology services outside the US.
Specific street address not publicly listed; operates from Oakland.
Oakland
CA
USA
Address: N/A (Remote Network)
To provide scalable and accessible dermatological consultations and care to patients across the United States, irrespective of their proximity to a physical clinic.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Apostrophe' leadership includes:
Apostrophe has been backed by several prominent investors over the years, including:
Focusing on Hims & Hers due to acquisition; specific Apostrophe brand executive changes are less publicized. Hims & Hers has seen some executive movements. For example, Soleil Teubner was appointed CFO in late 2022, later succeeded by Yemi Okupe.
Discover the tools Apostrophe uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Apostrophe is part of Hims & Hers, customer-facing emails for Apostrophe services would likely come from @apostrophe.com. Internal corporate emails might transition to @forhims.com or @forhers.com. Common formats include [first].[last] or [first_initial][last].
[first_initial][last]@apostrophe.com (e.g., jsmith@apostrophe.com) or [first].[last]@apostrophe.com (e.g., jane.smith@apostrophe.com)
Format
support@apostrophe.com (for customer service)
Example
70%
Success rate
MobiHealthNews • January 14, 2021
Hims & Hers Health, Inc. announced its acquisition of Apostrophe, a teledermatology company, for approximately $150 million in a mix of cash and stock. The deal aims to bolster Hims & Hers' capabilities in delivering personalized dermatology treatments....more
Hims & Hers Investor Relations • May 8, 2023
Hims & Hers, the parent company of Apostrophe, reported strong Q1 2023 financial results, highlighting growth in subscribers and revenue, reflecting positively on its portfolio of brands including its dermatology offerings....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Apostrophe, are just a search away.